Perth Children’s Hospital Opens New Clinical Trial for Children and Adolescents with Ewing Sarcoma
On the eve of Sarcoma and Bone Cancer Awareness Month, Perth Children’s Hospital has become the first international site outside of the United Kingdom to open an innovative clinical trial for children and adolescents with newly diagnosed Ewing Sarcoma.
Management of children with DIPG: ANZCHOG Position Statement
The ANZCHOG Central Nervous System (CNS) Tumour Group has recently published a position statement for the management of children with Diffuse Intrinsic Pontine Glioma (DIPG) in Australia and New Zealand.
Interfant-21 Opens at First Australian Site
Earlier this week, Perth Children’s Hospital became the first Australian site to open Interfant-21, an international phase 3 clinical trial.
Celebrating International Nurses Day
To celebrate the contribution nurses make within our community, we spoke with Chris Williams about his role as Regional Nurse Educator & Service Improvement Lead with the Victorian Paediatric Integrated Cancer Service (PICS).
Oncology Nursing Month – Meet Rachel Edwards
As Oncology Nursing Month comes to a close, we chatted with Rachel Edwards, a paediatric oncology research nurse, member of ANZCHOG’s Board of Directors and member of ANZCHOG’s Nursing Committee.
The Australian Cancer Plan
In this blog, we explore what the Australian Cancer Plan entails for children, adolescents and young adults.
Two promising ANZCHOG-sponsored clinical trials awarded funding by Australian Government
The Australian Government has awarded ANZCHOG more than $2.5 million in support of two international paediatric cancer clinical trials; BEACON2 and VICTORY.
A call to federal government for equitable access to a promising high-risk neuroblastoma treatment
Neuroblastoma Australia, together with ANZCHOG and Australian paediatric oncologists, has written to request the federal government urgently consider providing interim funding for Australian children with high-risk neuroblastoma to access eflornithine.